Ed Addison | Chief Executive Officer
Cloud Pharmaceuticals

Ed Addison is Chairman of Cloud Pharmaceuticals, a Research Triangle Park company from Duke University that applies AI to drug discovery and development and has a growing pipeline of novel drug candidates. Ed is further a technology adviser to Quantum Venture Management, an evergreen venture fund that focuses on technology and healthcare. With over 30 years of experience, Ed is on the advisory board or board of directors of a number of companies deploying novel technologies in life sciences, including Valor Diagnostics, Drug Logic, Parallel Profile, PolarisQB, and Quantum Cures Foundation.

With a technical background in Artificial Intelligence and Bioinformatics, and a strong business development and capital raising background, Ed is an industry executive, an adjunct professor and an established serial entrepreneur of disruptive ventures. Ed has three degrees in engineering (with a focus in bioinformatics and AI), an MBA and a law degree.